Market Research Logo

Canada Neurology Devices Market Outlook to 2023 - CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment

Canada Neurology Devices Market Outlook to 2023 - CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment

Summary

GlobalData’s new report, Canada Neurology Devices Market Outlook to 2023, provides key market data on the Canada Neurology Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment.
  • Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market categories.
  • Global corporate-level profiles of key companies operating within the Canada Neurology Devices market.
  • Key players covered include Medtronic plc, Boston Scientific Corp, St. Jude Medical LLC, LivaNova PLC and Others.
Reasons to buy
  • Develop business strategies by identifying the key market categories poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Neurology Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Neurology Devices Market, Canada
3.1 Neurology Devices Market, Canada, Revenue ($m), 2009-2023
3.4 Neurology Devices Market, Canada, Revenue ($m), 2009-2016
3.5 Neurology Devices Market, Canada, Revenue ($m), 2016-2023
3.6 Neurology Devices Market, Canada, Volume (Units), 2009-2023
3.7 Neurology Devices Market, Canada, Volume (Units), 2009-2016
3.8 Neurology Devices Market, Canada, Volume (Units), 2016-2023
3.9 Neurology Devices Market, Canada, Company Share by Revenue ($m), 2016
4 CSF Management Market, Canada
4.1 CSF Management Market, Canada, Revenue Mix ($m), 2016
4.2 CSF Management Market, Canada, Segment Contribution (%), 2016
4.3 CSF Management Market, Canada, Revenue ($m), 2009-2016
4.4 CSF Management Market, Canada, Revenue ($m), 2016-2023
4.5 CSF Management Market, Canada, Volume (Units), 2009-2016
4.6 CSF Management Market, Canada, Volume (Units), 2016-2023
4.7 CSF Management Market, Canada, Distribution Share by Revenue ($m), 2015-2016
4.8 CSF Management Market, Canada, Company Share by Revenue ($m), 2016
5 Interventional Neurology Market, Canada
5.1 Interventional Neurology Market, Canada, Revenue Mix ($m), 2016
5.2 Interventional Neurology Market, Canada, Segment Contribution (%), 2016
5.3 Interventional Neurology Market, Canada, Revenue ($m), 2009-2016
5.4 Interventional Neurology Market, Canada, Revenue ($m), 2016-2023
5.4.1 Embolization and Coiling Devices Market, Canada, Revenue ($m), by Segment, 2009-2016
5.4.2 Navigational System Market, Canada, Revenue ($m), by Segment, 2009-2016
5.4.3 Embolization and Coiling Devices Market, Canada, Revenue ($m), by Segment, 2016-2023
5.4.4 Navigational System Market, Canada, Revenue ($m), by Segment, 2016-2023
5.5 Interventional Neurology Market, Canada, Volume (Units), 2009-2016
5.6 Interventional Neurology Market, Canada, Volume (Units), 2016-2023
5.6.1 Embolization and Coiling Devices Market, Canada, Volume (Units), by Segment, 2009-2016
5.6.2 Navigational System Market, Canada, Volume (Units), by Segment, 2009-2016
5.6.3 Embolization and Coiling Devices Market, Canada, Volume (Units), by Segment, 2016-2023
5.6.4 Navigational System Market, Canada, Volume (Units), by Segment, 2016-2023
5.7 Interventional Neurology Market, Canada, Distribution Share by Revenue ($m), 2015-2016
5.8 Interventional Neurology Market, Canada, Company Share by Revenue ($m), 2016
6 Neurological Diagnostic Equipment Market, Canada
6.1 Neurological Diagnostic Equipment Market, Canada, Revenue Mix ($m), 2016
6.2 Neurological Diagnostic Equipment Market, Canada, Segment Contribution (%), 2016
3.1 Neurological Diagnostic Equipment Market, Canada, Revenue ($m), 2009-2016
3.2 Neurological Diagnostic Equipment Market, Canada, Revenue ($m), 2016-2023
3.3 Neurological Diagnostic Equipment Market, Canada, Volume (Units), 2009-2016
3.4 Neurological Diagnostic Equipment Market, Canada, Volume (Units), 2016-2023
3.6 Neurological Diagnostic Equipment Market, Canada, Distribution Share by Revenue ($m), 2015-2016
3.7 Neurological Diagnostic Equipment Market, Canada, Company Share by Revenue ($m), 2016
7 Neurostimulation Devices Market, Canada
7.1 Neurostimulation Devices Market, Canada, Revenue Mix ($m), 2016
7.2 Neurostimulation Devices Market, Canada, Segment Contribution (%), 2016
7.3 Neurological Diagnostic Equipment Market, Canada, Revenue ($m), 2009-2016
7.4 Neurological Diagnostic Equipment Market, Canada, Revenue ($m), 2016-2023
7.5 Neurological Diagnostic Equipment Market, Canada, Volume (Units), 2009-2016
7.6 Neurological Diagnostic Equipment Market, Canada, Volume (Units), 2016-2023
7.7 Neurological Diagnostic Equipment Market, Canada, Distribution Share by Revenue ($m), 2015-2016
7.8 Neurological Diagnostic Equipment Market, Canada, Company Share by Revenue ($m), 2016
8 Neurosurgical Products Market, Canada
8.1 Neurosurgical Products Market, Canada, Revenue Mix ($m), 2016
8.2 Neurosurgical Products Market, Canada, Segment Contribution (%), 2016
8.3 Neurosurgical Products Market, Canada, Revenue ($m), 2009-2016
8.4 Neurosurgical Products Market, Canada, Revenue ($m), 2016-2023
8.5 Neurosurgical Products Market, Canada, Volume (Units), 2009-2016
8.6 Neurosurgical Products Market, Canada, Volume (Units), 2016-2023
8.7 Neurosurgical Products Market, Canada, Distribution Share by Revenue ($m), 2015-2016
8.8 Neurosurgical Products Market, Canada, Company Share by Revenue ($m), 2016
9 Radiosurgery Market, Canada
9.1 Radiosurgery Market, Canada, Revenue ($m), 2009-2016
9.2 Radiosurgery Market, Canada, Volume (Units), 2009-2016
10 Overview of Key Companies in Canada, Neurology Devices Market
10.1 Medtronic Plc
10.1.1 Company Overview
10.2 DePuy Synthes Inc
10.2.1 Company Overview
10.3 Integra LifeSciences Holdings Corp
10.3.1 Company Overview
10.4 Natus Medical Incorporated
10.4.1 Company Overview
10.5 Stryker Corporation
10.5.1 Company Overview
10.6 B. Braun Melsungen AG
10.6.1 Company Overview
10.7 Boston Scientific Corp
10.7.1 Company Overview
10.8 St. Jude Medical LLC
10.8.1 Company Overview
10.9 Nihon Kohden Corp
10.9.1 Company Overview
10.10 LivaNova PLC
10.10.1 Company Overview
11 Neurology Devices Market Pipeline Products
12 Financial Deals Landscape
12.1 Debt Offerings
12.1.1 M Pharma Raises USD1.5 Million in First Tranche of Private Placement of 10% Debentures Due 2019
12.2 Equity Offerings
12.2.1 Sierra Oncology Prices Public Offering of Shares for USD26.3 Million
12.3 Partnerships
12.3.1 Colorado State University and Synaptive Medical Enter into Partnership
12.4 Private Equity
12.4.1 General Atlantic Invests in Synaptive Medical
12.5 Venture Financing
12.5.1 Evasc Medical Systems Raises USD7.5 Million in Series A Financing
12.5.2 Synaptive Medical Raises USD1 Million in Venture Financing
12.5.3 NeuroQore Secures Venture Funding from IndieBio
12.5.4 Synaptive Medical Raises Additional USD0.3 Million in Venture Financing
12.5.5 Synaptive Medical Raises USD3.4 Millio in Venture Financing
13 Recent Developments
13.1 Corporate Communications
13.1.1 Mar 23, 2017: Synaptive Medical Expands Medtech Expertise Through Board Additions
13.1.2 Jan 09, 2017: New Study Shows 3D Signatures' Telomere Analysis May Be an Effective Biomarker for Monitoring High Risk Prostate Cancer Patients
13.2 Financial Announcements
13.2.1 May 09, 2017: Sierra Oncology Reports First Quarter 2017 Results
13.2.2 Mar 15, 2017: Prima BioMed Completes Recruitment for Second Patient Cohort in Melanoma Trial and Will Present at ICI Conference in Boston
13.2.3 Mar 02, 2017: Sierra Oncology Reports 2016 Year-End Results
13.2.4 Feb 28, 2017: Results for the second quarter of Fiscal year 2017 - Ergoresearch reports its results for the quarter ended December 31, 2016
13.2.5 Nov 28, 2016: Results for the first quarter of Fiscal year 2017 - Ergoresearch reports its results for the quarter ended
13.2.6 Nov 28, 2016: Ergoresearch reports its results for the quarter ended September 30, 2016
13.2.7 Oct 28, 2016: Results for the fourth quarter and the fiscal year ended June 30, 2016 - Ergoresearch reports its 2016 annual results
13.3 Legal And Regulatory
13.3.1 May 23, 2017: KARL STORZ Wins Inter Partes Review Trial Invalidating Novadaq Patent
13.3.2 Feb 03, 2017: Easton Pharmaceuticals and BMV Medica Announces First Shipment of Gynofit To Multi-National Pharmaceutical Company, Gedeon Richter, Towards Its Purchase Order, Has Been Received For February 16th Product Launch in Puerto Vallarta, Mexico
13.3.3 Jan 09, 2017: ProNAi Relaunched as Sierra Oncology to Advance DDR-Based Cancer Drugs
13.3.4 Jul 06, 2016: U.S. patent trial and appeal board grants ZEISS' petition and institutes IPR against NPE patent holder AMI
13.4 Other Significant Developments
13.4.1 May 02, 2017: University of Oklahoma Medical Center First in State to Acquire Advanced Technology for Brain Surgery
13.4.2 Apr 10, 2017: Rapid blood test for intracranial hemorrhage in well appearing infants: a comprehensive brain injury study using Axela’s Flow-Thru Chip platform
13.4.3 Feb 28, 2017: Government of Canada Invests in Research to Advance Patient Care
13.4.4 Sep 29, 2016: Croton Healthcare Canada, York Instruments & Simon Fraser University Undertake Clinical Study Of MEG Effectiveness In Diagnosing Brain Concussions
13.5 Product News
13.5.1 Nov 08, 2016: Medtronic the first to offer complete portfolio of full-body MR conditional neurostimulation systems for chronic pain in Canada
13.5.2 Oct 26, 2016: Synaptive Medical to Showcase BrightMatter Technology at North American Spine Society in Boston
13.5.3 Aug 31, 2016: Scientists discover non-invasive technique to monitor migraines
13.5.4 Jul 15, 2016: Alzheimer’s Association International Conference 2016
13.5.5 Jul 08, 2016: Canadian company gives hope to Alzheimer's sufferers with wearable low-level light therapy
14 Appendix
14.1 Research Methodology
14.1.1 Coverage
14.1.2 Secondary Research
14.1.3 Primary Research
14.1.4 Company Share Analysis
14.1.5 Distribution Share Analysis
14.1.6 Benchmarking
14.2 GlobalData Consulting
14.3 Contact Us
14.4 Disclaimer
1.1 List of Tables
Table 1: Neurology Devices Market, Canada, Revenue ($m), USD Constant, 2009-2023
Table 2: Neurology Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Table 3: Neurology Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 4: Neurology Devices Market, Canada, Volume (Units), 2009-2023
Table 5: Neurology Devices Market, Canada, Volume (Units), Historic, 2009-2016
Table 6: Neurology Devices Market, Canada, Volume (Units), Forecast, 2016-2023
Table 7: Neurology Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2016
Table 8: CSF Management Market, Canada, Segment Contribution (%), 2016
Table 9: CSF Management Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Table 10: CSF Management Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 11: CSF Management Market, Canada, Volume (Units), Historic, 2009-2016
Table 12: CSF Management Market, Canada, Volume (Units), Forecast, 2016-2023
Table 13: CSF Management Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 14: CSF Management Market, Canada, Company Share by Revenue ($m), USD Constant, 2016
Table 15: Interventional Neurology Market, Canada, Segment Contribution (%), 2016
Table 16: Interventional Neurology Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Table 17: Interventional Neurology Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 18: Embolization and Coiling Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Table 19: Navigational System Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Table 20: Embolization and Coiling Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 21: Navigational System Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 22: Interventional Neurology Market, Canada, Volume (Units), Historic, 2009-2016
Table 23: Interventional Neurology Market, Canada, Volume (Units), Forecast, 2016-2023
Table 24: Embolization and Coiling Devices Market, Canada, Volume (Units), Historic, 2009-2016
Table 25: Navigational System Market, Canada, Volume (Units), Historic, 2009-2016
Table 26: Embolization and Coiling Devices Market, Canada, Volume (Units), Forecast, 2016-2023
Table 27: Navigational System Market, Canada, Volume (Units), Forecast, 2016-2023
Table 28: Interventional Neurology Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 29: Interventional Neurology Market, Canada, Company Share by Revenue ($m), USD Constant, 2016
Table 30: Neurological Diagnostic Equipment Market, Canada, Segment Contribution (%), 2016
Table 31: Neurological Diagnostic Equipment Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Table 32: Neurological Diagnostic Equipment Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 33: Neurological Diagnostic Equipment Market, Canada, Volume (Units), Historic, 2009-2016
Table 34: Neurological Diagnostic Equipment Market, Canada, Volume (Units), Forecast, 2016-2023
Table 35: Neurological Diagnostic Equipment Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 36: Neurological Diagnostic Equipment Market, Canada, Company Share by Revenue ($m), USD Constant, 2016
Table 37: Neurostimulation Devices Market, Canada, Segment Contribution (%), 2016
Table 38: Neurological Diagnostic Equipment Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Table 39: Neurological Diagnostic Equipment Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 40: Neurological Diagnostic Equipment Market, Canada, Volume (Units), Historic, 2009-2016
Table 41: Neurological Diagnostic Equipment Market, Canada, Volume (Units), Forecast, 2016-2023
Table 42: Neurological Diagnostic Equipment Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 43: Neurological Diagnostic Equipment Market, Canada, Company Share by Revenue ($m), USD Constant, 2016
Table 44: Neurosurgical Products Market, Canada, Segment Contribution (%), 2016
Table 45: Neurosurgical Products Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Table 46: Neurosurgical Products Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 47: Neurosurgical Products Market, Canada, Volume (Units), Historic, 2009-2016
Table 48: Neurosurgical Products Market, Canada, Volume (Units), Forecast, 2016-2023
Table 49: Neurosurgical Products Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 50: Neurosurgical Products Market, Canada, Company Share by Revenue ($m), USD Constant, 2016
Table 51: Radiosurgery Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Table 52: Radiosurgery Market, Canada, Volume (Units), Historic, 2009-2016
Table 53: Neurology Devices Market Pipeline Products
Table 54: M Pharma Raises USD1.5 Million in First Tranche of Private Placement of 10% Debentures Due 2019
Table 55: Sierra Oncology Prices Public Offering of Shares for USD26.3 Million
Table 56: Colorado State University and Synaptive Medical Enter into Partnership
Table 57: General Atlantic Invests in Synaptive Medical
Table 58: Evasc Medical Systems Raises USD7.5 Million in Series A Financing
Table 59: Synaptive Medical Raises USD1 Million in Venture Financing
Table 60: NeuroQore Secures Venture Funding from IndieBio
Table 61: Synaptive Medical Raises Additional USD0.3 Million in Venture Financing
Table 62: Synaptive Medical Raises USD3.4 Millio in Venture Financing
1.2 List of Figures
Figure 1: Neurology Devices Market, Canada, Revenue ($m), USD Constant, 2009-2023
Figure 2: Neurology Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 3: Neurology Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 4: Neurology Devices Market, Canada, Volume (Units), 2009-2023
Figure 5: Neurology Devices Market, Canada, Volume (Units), Historic, 2009-2016
Figure 6: Neurology Devices Market, Canada, Volume (Units), Forecast, 2016-2023
Figure 7: Neurology Devices Market, Canada, Company Share (%) 2016
Figure 8: CSF Management Market, Canada, Revenue Mix ($m), 2016
Figure 9: CSF Management Market, Canada, Segment Contribution (%), 2016
Figure 10: CSF Management Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 11: CSF Management Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 12: CSF Management Market, Canada, Volume (Units), Historic, 2009-2016
Figure 13: CSF Management Market, Canada, Volume (Units), Forecast, 2016-2023
Figure 14: CSF Management Market, Canada, Company Share (%) 2016
Figure 15: Interventional Neurology Market, Canada, Revenue Mix ($m), 2016
Figure 16: Interventional Neurology Market, Canada, Segment Contribution (%), 2016
Figure 17: Interventional Neurology Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 18: Interventional Neurology Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 19: Embolization and Coiling Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 20: Navigational System Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 21: Embolization and Coiling Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 22: Navigational System Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 23: Interventional Neurology Market, Canada, Volume (Units), Historic, 2009-2016
igure 24: Interventional Neurology Market, Canada, Volume (Units), Forecast, 2016-2023
Figure 25: Embolization and Coiling Devices Market, Canada, Volume (Units), Historic, 2009-2016
Figure 26: Navigational System Market, Canada, Volume (Units), Historic, 2009-2016
Figure 27: Embolization and Coiling Devices Market, Canada, Volume (Units), Forecast, 2016-2023
Figure 28: Navigational System Market, Canada, Volume (Units), Forecast, 2016-2023
Figure 29: Interventional Neurology Market, Canada, Company Share (%) 2016
Figure 30: Neurological Diagnostic Equipment Market, Canada, Revenue Mix ($m), 2016
Figure 31: Neurological Diagnostic Equipment Market, Canada, Segment Contribution (%), 2016
Figure 32: Neurological Diagnostic Equipment Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 33: Neurological Diagnostic Equipment Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 34: Neurological Diagnostic Equipment Market, Canada, Volume (Units), Historic, 2009-2016
Figure 35: Neurological Diagnostic Equipment Market, Canada, Volume (Units), Forecast, 2016-2023
Figure 36: Neurological Diagnostic Equipment Market, Canada, Company Share (%) 2016
Figure 37: Neurostimulation Devices Market, Canada, Revenue Mix ($m), 2016
Figure 38: Neurostimulation Devices Market, Canada, Segment Contribution (%), 2016
Figure 39: Neurological Diagnostic Equipment Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 40: Neurological Diagnostic Equipment Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 41: Neurological Diagnostic Equipment Market, Canada, Volume (Units), Historic, 2009-2016
Figure 42: Neurological Diagnostic Equipment Market, Canada, Volume (Units), Forecast, 2016-2023
Figure 43: Neurological Diagnostic Equipment Market, Canada, Company Share (%) 2016
Figure 44: Neurosurgical Products Market, Canada, Revenue Mix ($m), 2016
Figure 45: Neurosurgical Products Market, Canada, Segment Contribution (%), 2016
Figure 46: Neurosurgical Products Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 47: Neurosurgical Products Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 48: Neurosurgical Products Market, Canada, Volume (Units), Historic, 2009-2016
Figure 49: Neurosurgical Products Market, Canada, Volume (Units), Forecast, 2016-2023
Figure 50: Neurosurgical Products Market, Canada, Company Share (%) 2016
Figure 51: Radiosurgery Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 52: Radiosurgery Market, Canada, Volume (Units), Historic, 2009-2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report